Loading Icon

Erlotinib

Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. Specifically it is used for NSCLC with mutations in the epidermal growth factor receptor (EGFR) — either an exon 19 deletion (del19) or exon 21 (L858R) substitution mutation — which has spread to other parts of the body. It is taken by mouth.

Metrics Summary

Total Publications
Lifetime
4,943
Prior Five Years
1,163
Total Citations
Lifetime
126,517
Prior Five Years
10,375
Total Scholars
Lifetime
14,308
Prior Five Years
12,346

Institutional Rankings

Global (Worldwide)
Show More
National Institutional Rankings

Publications and Citation History

Publications based on Disciplines

Scholars based on Disciplines

Publications based on Fields

Scholars based on Fields

Highly Ranked Scholars™

Lifetime
Prior Five Years

Highly Cited Publications

Lifetime